EcoDrugPlus

Mitogen-Activated Protein Kinase Kinase Kinase 8

Ensembl ID : ENSFHEG00000007591
Gene Symbol: MAP3K8
3 Cross references
201 Possible Orthologues:

Mitogen-Activated Protein Kinase Kinase Kinase 9

Ensembl ID : ENSFHEG00000004567
Gene Symbol: MAP3K9
3 Cross references
194 Possible Orthologues:

Monoglyceride Lipase

Ensembl ID : ENSFHEG00000018523
Gene Symbol: MGLL
3 Cross references
208 Possible Orthologues:

Motilin Receptor

Ensembl ID : ENSFHEG00000013824
Gene Symbol: MLNR
3 Cross references
172 Possible Orthologues:

Muscarinic Acetylcholine Receptor M4-Like

Ensembl ID : ENSFHEG00000019794
Gene Symbol: LOC105936503
2 Cross references
186 Possible Orthologues:

Muscarinic Acetylcholine Receptor M5-Like

Ensembl ID : ENSFHEG00000009710
Gene Symbol: LOC105936294
3 Cross references
190 Possible Orthologues:

Natriuretic Peptide Receptor 1

Ensembl ID : ENSFHEG00000016896
Gene Symbol: NPR1
3 Cross references
194 Possible Orthologues:

Natriuretic Peptide Receptor 2

Ensembl ID : ENSFHEG00000016848
Gene Symbol: NPR2
2 Cross references
186 Possible Orthologues:

Natriuretic Peptide Receptor 2

Ensembl ID : ENSFHEG00000012900
Gene Symbol: NPR2
3 Cross references
191 Possible Orthologues:

Neurogenic Locus Notch Homolog Protein 1-Like

Ensembl ID : ENSFHEG00000007960
Gene Symbol: LOC105930009
3 Cross references
195 Possible Orthologues:

Neurogenic Locus Notch Homolog Protein 2-Like

Ensembl ID : ENSFHEG00000001455
Gene Symbol: LOC105937328
3 Cross references
194 Possible Orthologues:

Neuromedin-K Receptor-Like

Ensembl ID : ENSFHEG00000022855
Gene Symbol: LOC105915629
3 Cross references
201 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).